Jian Su
Impact in
- Oncology top 0.5%
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
- Colorectal Cancer Treatments and Studies
- Pulmonary and Respiratory Medicine top 0.5%
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
- Ferroptosis and cancer prognosis
Papers in
-
- Lung Cancer Treatments and Mutations 79
- Lung Cancer Diagnosis and Treatment 18
- Ferroptosis and cancer prognosis 8
- Oncology 67
- Lung Cancer Research Studies 27
- Colorectal Cancer Treatments and Studies 19
- Cancer Immunotherapy and Biomarkers 16
- Co-authors
- Yi‐Long Wu (90 shared papers)Wen‐Zhao Zhong (55 shared papers)Xu‐Chao Zhang (63 shared papers)Qing Zhou (55 shared papers)Jin‐Ji Yang (44 shared papers)Hong‐Hong Yan (42 shared papers)Zhi Xie (29 shared papers)Hai‐Yan Tu (35 shared papers)
- Journals
- Journal of Thoracic Oncology (18 papers)Journal of Clinical Oncology (12 papers)Oncotarget (5 papers)Clinical Lung Cancer (5 papers)BMC Cancer (4 papers)
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Jian Su
125 papers receiving 4.5k citations
Jian Su's Hit Papers
Peers
Comparison fields: 5 of 110
- Oncology 2.8k
- Pulmonary and Respiratory Medicine 3.1k
- Cancer Research 1.3k
- Molecular Biology 1.4k
- Immunology 420
Countries citing papers authored by Jian Su
This map shows the geographic impact of Jian Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jian Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jian Su more than expected).
Fields of papers citing papers by Jian Su
This network shows the impact of papers produced by Jian Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jian Su. The network helps show where Jian Su may publish in the future.
Co-authors
The 25 scholars most cited alongside Jian Su, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 136 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Potential Predictive Value of TP53 and KRAS Mutation Status for Response to PD-1 Blockade Immunotherapy in Lung Adenocarcinoma Hit paper breakdown → | 2016 | 741 |
| 2 | EGFR mutation correlates with uninflamed phenotype and weak immunogenicity, causing impaired response to PD-1 blockade in non-small cell lung cancer Hit paper breakdown → | 2017 | 333 |
| 3 | 2011 | 199 | |
| 4 | 2012 | 141 | |
| 5 | 2012 | 140 | |
| 6 | 2017 | 136 | |
| 7 | 2014 | 135 | |
| 8 | 2012 | 133 | |
| 9 | 2019 | 127 | |
| 10 | 2017 | 120 | |
| 11 | 2020 | 113 | |
| 12 | 2018 | 101 | |
| 13 | 2015 | 87 | |
| 14 | 2009 | 86 | |
| 15 | 2016 | 78 | |
| 16 | 2012 | 76 | |
| 17 | 2019 | 75 | |
| 18 | 2017 | 74 | |
| 19 | 2015 | 67 | |
| 20 | 2016 | 63 |
About Jian Su
Jian Su is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Cancer Research, Molecular Biology and Surgery, having authored 136 papers that have together received 4.6k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (79 papers), Cancer Genomics and Diagnostics (31 papers), Lung Cancer Research Studies (27 papers), Colorectal Cancer Treatments and Studies (19 papers), Lung Cancer Diagnosis and Treatment (18 papers), Cancer Immunotherapy and Biomarkers (16 papers), Ferroptosis and cancer prognosis (8 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (8 papers). The work is most often cited by research in Oncology (2.8k citations), Pulmonary and Respiratory Medicine (3.1k citations), Cancer Research (1.3k citations), Molecular Biology (1.4k citations) and Immunology (420 citations). Jian Su has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Yi‐Long Wu, Wen‐Zhao Zhong, Xu‐Chao Zhang, Qing Zhou, Jin‐Ji Yang, Hong‐Hong Yan, Zhi Xie, Hai‐Yan Tu, Xue‐Ning Yang and Zhong‐Yi Dong. Their work appears in journals such as Journal of Thoracic Oncology, Journal of Clinical Oncology, Oncotarget, Clinical Lung Cancer and BMC Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.